Prescription drug · NDA
Uzedy (Risperidone) NDC 51759-410
Risperidone 75 mg/.21mL · Injection, Suspension, Extended release · Subcutaneous · Teva Pharmaceuticals USA, Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 51759-410-10 | 51759041010 | 1 SYRINGE, GLASS in 1 CARTON (51759-410-10) / .21 mL in 1 SYRINGE, GLASSMarketed from May 1, 2023 | |
| 51759-410-11 | 51759041011 | 1 SYRINGE, GLASS in 1 CARTON (51759-410-11) / .21 mL in 1 SYRINGE, GLASSMarketed from May 1, 2023 · Sample package |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Uzedy
- Generic name (nonproprietary)
- risperidone
- Active ingredients
- Risperidone — 75 mg/.21mL
- Dosage form
- Injection, Suspension, Extended release
- Route
- Subcutaneous
- Labeler
- Teva Pharmaceuticals USA, Inc.NDC labeler code 51759
- Product type
- Prescription drug
- Marketing category
- NDA — New Drug ApplicationApplication NDA 213586
- Marketing start
- Listing expires
- Identifiers
- Product ID 51759-410_fbc54ee2-4211-4765-a288-75778def0f5aSPL ID fbc54ee2-4211-4765-a288-75778def0f5a
- Pharmacologic class
- Atypical Antipsychotic
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- Administration
Drug administration (CPT 96360–96549)
When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.
- NDC on a medical claim
N451759041010followed by a unit qualifier and the quantityPackage 51759-0410-10. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
The FDA listing for this product does not reference a label (SPL) set.
About NDC 51759-410
- What is NDC 51759-410?
- 51759-410 is the product NDC for Uzedy (risperidone), Risperidone 75 mg/.21mL injection, suspension, extended release, listed with the FDA by Teva Pharmaceuticals USA, Inc.. It has 2 package NDCs, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Uzedy (Risperidone).
- What is the active ingredient?
- Risperidone.
- Who is the labeler?
- Teva Pharmaceuticals USA, Inc., NDC labeler code 51759. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Uzedy?
- 6 other product NDCs are listed under this name. See all Uzedy NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Uzedy products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Uzedyrisperidone | Risperidone 50 mg/.14mL | Injection, Suspension, Extended releaseSubcutaneous | Teva Pharmaceuticals USA, Inc. | 51759-305 | 51759-0305-1051759-0305-11 |
| Uzedyrisperidone | Risperidone 100 mg/.28mL | Injection, Suspension, Extended releaseSubcutaneous | Teva Pharmaceuticals USA, Inc. | 51759-520 | 51759-0520-1051759-0520-11 |
| Uzedyrisperidone | Risperidone 125 mg/.35mL | Injection, Suspension, Extended releaseSubcutaneous | Teva Pharmaceuticals USA, Inc. | 51759-630 | 51759-0630-1051759-0630-11 |
| Uzedyrisperidone | Risperidone 150 mg/.42mL | Injection, Suspension, Extended releaseSubcutaneous | Teva Pharmaceuticals USA, Inc. | 51759-740 | 51759-0740-1051759-0740-11 |
| Uzedyrisperidone | Risperidone 200 mg/.56mL | Injection, Suspension, Extended releaseSubcutaneous | Teva Pharmaceuticals USA, Inc. | 51759-850 | 51759-0850-1051759-0850-11 |
| Uzedyrisperidone | Risperidone 250 mg/.7mL | Injection, Suspension, Extended releaseSubcutaneous | Teva Pharmaceuticals USA, Inc. | 51759-960 | 51759-0960-1051759-0960-11 |
Other NDCs under NDA 213586
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Uzedyrisperidone | Risperidone 50 mg/.14mL | Injection, Suspension, Extended releaseSubcutaneous | Teva Pharmaceuticals USA, Inc. | 51759-305 |
| Uzedyrisperidone | Risperidone 100 mg/.28mL | Injection, Suspension, Extended releaseSubcutaneous | Teva Pharmaceuticals USA, Inc. | 51759-520 |
| Uzedyrisperidone | Risperidone 125 mg/.35mL | Injection, Suspension, Extended releaseSubcutaneous | Teva Pharmaceuticals USA, Inc. | 51759-630 |
| Uzedyrisperidone | Risperidone 250 mg/.7mL | Injection, Suspension, Extended releaseSubcutaneous | Teva Pharmaceuticals USA, Inc. | 51759-960 |
| Uzedyrisperidone | Risperidone 150 mg/.42mL | Injection, Suspension, Extended releaseSubcutaneous | Teva Pharmaceuticals USA, Inc. | 51759-740 |
| Uzedyrisperidone | Risperidone 200 mg/.56mL | Injection, Suspension, Extended releaseSubcutaneous | Teva Pharmaceuticals USA, Inc. | 51759-850 |